Axsome Therapeutics (AXSM) Competitor Comparison
We are evaluating the key criteria listed to compare Axsome Therapeutics (AXSM) against its competitors in the Biotechnology industry.
Market Capitalization
44 / 368Gross Profits
66 / 278Total Revenue
54 / 300EBITDA
272 / 337Free Cashflow
250 / 352Quick Ratio
201 / 357Earnings per Share
322 / 359Dividend yield
0 / 6Total Cash
73 / 358Performance 3 years
31 / 368Performance 5 years
33 / 368Performance 10 years
10 / 368Linearity 3 years
331 / 368Linearity 5 years
324 / 368Linearity 10 years
361 / 368Total Rank
209 / 368Dividend Rank
53 / 368Valuation Rank
90 / 368Piotroski Rank
43 / 368Muliplier Rank
286 / 368Gross Profits - AXSM ranking 66 / 278
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.